RxSight (RXST) Total Current Liabilities (2020 - 2026)

RxSight (RXST) has 7 years of Total Current Liabilities data on file, last reported at $27.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 20.38% year-over-year to $27.4 million; the trailing twelve-month figure through Mar 2026 stood at $27.4 million (up 20.38% YoY), and the FY2025 full-year result was $26.3 million, up 1.46% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $27.4 million, up from $26.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $27.4 million in Q1 2026 and bottomed at $10.7 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $19.6 million (2024), against an average of $19.6 million.
• The widest annual swing landed in 2022, when Total Current Liabilities surged 78.38%; it then slipped 1.53% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $17.2 million in 2022, then grew by 21.27% to $20.9 million in 2023, then rose by 23.79% to $25.9 million in 2024, then gained by 1.46% to $26.3 million in 2025, then rose by 4.28% to $27.4 million in 2026.
• The last three Total Current Liabilities figures came in at $27.4 million (Q1 2026), $26.3 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.

Peer Comparison